1. I am interested in the medicines optimisation contract currently in place. Are you able to share the winning tender documentation from the last procurement round and the original procurement budget for these services? I understand the contract value was £442k
We are pleased to provide you with the details of the original procurement budget for the Medicines Optimisation contract which was awarded in September 2015. This budget was £450,000. The contract value was £442,324. You can find further details under the CCGs Publication Scheme which can be found on our public web site at the following link:
We can confirm that we hold the winning tender documentation from the last Medicines Optimisation Procurement in 2015. However, we are currently in a live procurement phase for the Medicines Optimisation Contract. As a result we are, unfortunately, unable to provide you with the winning tender documentation from the last procurement. We are withholding this information under Section 43(2) of the Freedom of Information Act 2000. Section 43(2) of the Act allows a public organisation to withhold information where the release of the information is likely to prejudice the commercial interests of any person (a person may be an individual, a company, the public authority itself or any other legal entity).
Section 43(2) of the Freedom of Information Act is a prejudice-based exemption, so the test for exempting information from disclosure is whether or not commercial interests would, or would be likely to, be prejudiced by disclosure.
As we are currently in a live procurement phase for the Medicines Optimisation Contract we believe the level of competition in the current tendering exercise would no longer be equal should the winning tender documentation from the previous procurement be released. We believe the likelihood of prejudice being caused at this time of a live procurement is currently reasonably high. If the previous winning tender documents were released these could be used unfairly to ensure any bids included information that would help a bidder win the contract, elevating the risk that an unsuitable provider would then win the contract. Whilst the information is refused at this point in time it does not mean it will be permanently withheld. To note any future disclosure may be subject to redaction of text which we believe continues to be commercially sensitive following closure of the tendering exercise.